Literature DB >> 13904311

Studies on mortality in chick embryos resulting from implantation of whole blood and blood fractions from patients and animals with neoplastic disease.

A H HANDLER, C F GEISER, S FARBER.   

Abstract

Entities:  

Keywords:  BLOOD TRANSFUSION/experimental; EMBRYO; NEOPLASMS/blood

Mesh：

Year:  1962        PMID： 13904311      PMCID： PMC220996          DOI： 10.1073/pnas.48.9.1549

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  6 in total

1.  Mortality in chick embryos following implantation of cells and cell fractions of heterologous leukemias.

Authors:  A H HANDLER; S I MAGALINI; S L SNEGIREFF
Journal:  Plast Reconstr Surg       Date:  1961-10       Impact factor: 4.730

2.  Chemotherapy studies on transplantable human and animal tumors in Syrian hamsters.

Authors:  A H HANDLER
Journal:  Ann N Y Acad Sci       Date:  1958-12-05       Impact factor: 5.691

3.  Study of toxic factors associated with mouse mammary carcinomas in egg cultures.

Authors:  N G MCDUFFIE; B S GIBSON; A TAYLOR
Journal:  Cancer Res       Date:  1960-12       Impact factor: 12.701

4.  Toxic factor associated with egg-cultivated tumors.

Authors:  A TAYLOR; N CARMICHAEL
Journal:  Cancer Res       Date:  1960-12       Impact factor: 12.701

5.  Experimental increase of lung metastases after operative trauma (amputation of limb with tumor).

Authors:  M R LEWIS; W H COLE
Journal:  AMA Arch Surg       Date:  1958-10

6.  Production of the milk agent in cultures of mouse mammary carcinoma.

Authors:  E Y LASFARGUES; D H MOORE; M R MURRAY; C D HAAGENSEN; E C POLLARD
Journal:  J Biophys Biochem Cytol       Date:  1959-01-25
  6 in total
  1 in total

1.  Preclinical therapeutics ex ovo quail eggs as a biomimetic automation-ready xenograft platform.

Authors:  Samuel V Rasmussen; Noah E Berlow; Lisa Hudson Price; Atiya Mansoor; Stefano Cairo; Sandra Rugonyi; Charles Keller
Journal:  Sci Rep       Date:  2021-12-02       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.